About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,988 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,988 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1881-1900 of 7,988 trials

CompletedPh II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLCRATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00283244·Fayetteville, Arkansas and 10 others CompletedBupropion in Helping Adults Stop SmokingRATIONALE: Bupropion may help people stop smoking by decreasing the symptoms of nicotine withdrawal.NCT00534001·Buffalo, New York CompletedPowered Echelon Device in VATS SurgeryThis study aims to collect real world outcomes of Video-Assisted Thoracoscopic Surgery (VATS) for lung cancer (lobectomy, wedge resection) using ECHELON FLEX™ Powered ENDOPATH®…NCT01808430·Odense

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedIcotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR MutationAdjuvant therapy has been proved effective in treating earlier stage or less advanced non-small-cell lung cancer.NCT02044328·Beijing, Beijing Municipality

CompletedA Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesThis is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and…NCT02571036·Scottsdale, Arizona and 25 others

Enrolling by invitationEfficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.Efficacy and safety evaluation of PLB1004 in patients with locally advanced/metastatic non-squamous NSCLCharboring EGFR exon 20 insertion.NCT06281964·Guangzhou, Guangzhou

RecruitingA PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving PembrolizumabThis phase I trial studies the safety and side effects of a new positron emission tomography (PET) imaging agent called 64Cu-DOTA-pembrolizumab to see how well it works in…NCT07619599·Duarte, California

RecruitingA Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to test CPO301, a type of drug called an antibody drug conjugate in adult patients with advanced or metastatic solid tumors.NCT05948865·Los Angeles, California and 13 others

CompletedCelecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Celecoxib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00104767·Los Angeles, California

RecruitingLarge Granular Lymphocytes in mNSCLC Treated With NivolumabLarge granular lymphocytes (LGLs), which constitute 10-15% of peripheral blood mononuclear cells, are large lymphocytes with a round nucleus, large cytoplasm, and azurophilic…NCT07363811·Konya, Meram

CompletedDose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsA first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients with advanced or metastatic solid…NCT05479812·Scottsdale, Arizona and 13 others

RecruitingPulmonary Rehabilitation in Advanced Lung Cancer SurvivorsThis study is for people who have previously been diagnosed with advanced stage non-small cell lung cancer (NSCLC).NCT07104630·Cleveland, Ohio

Not yet recruitingA Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLCThis study is a single-arm, multicenter real-world clinical study designed to evaluate the safety and efficacy of Leucogen (a leukocyte-increasing agent) as a prophylactic…NCT07418879

Active not recruitingA Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsThe purpose of this study is to test the safety and tolerability of HFB200301 as a single agent and in combination with tislelizumab in patients with advanced cancers.NCT05238883·Scottsdale, Arizona and 9 others

RecruitingDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLCThe goal of this observational study is to learn whether tumor and nodal downstaging after neoadjuvant chemo-immunotherapy is associated with better surgical outcomes in patients…NCT07528066·Fuzhou, Fujian and 9 others

CompletedIxabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung CancerThis is a multicenter, non-randomized, Phase II study of patients with previously untreated NSCLC not amenable to radiotherapy or surgical treatment.NCT00741988·Fort Myers, Florida and 12 others

UnknownAdjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLCOxaliplatin has a more manageable toxicity profile than cisplatin, with no renal toxicity and a lower incidence of hematological and gastrointestinal toxicities.NCT00452881·Goyang-si, Gyeonggi-do

CompletedA Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung CancerThis is a randomized, double-blind, placebo-controlled, multi-center Phase II clinical trial to evaluate the efficacy and safety of Fruquintinib plus best supportive care in…NCT02590965·Beijing, Beijing Municipality and 11 others

CompletedA Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLCA Randomized, Double-blind, Controlled, Multi-center Phase 2 Clinical study to Investigate the Efficacy and Safety of Tucidinostat (Chidamide) Combined with Tislelizumab as…NCT05519865·Shanghai, Shanghai Municipality

UnknownPre Radiotherapy Daily Exercise Training in Non-Small Cell Lung CancerThe aim of this study is to evaluate the feasibility and the effect of daily, individual, supervised and structured exercise training before radiotherapy in patients diagnosed…NCT03066271·Copenhagen

PreviousPage 95 of 400Next